1. Home
  2. TBPH vs BZH Comparison

TBPH vs BZH Comparison

Compare TBPH & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • BZH
  • Stock Information
  • Founded
  • TBPH 2013
  • BZH 1985
  • Country
  • TBPH United States
  • BZH United States
  • Employees
  • TBPH N/A
  • BZH N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • BZH Homebuilding
  • Sector
  • TBPH Health Care
  • BZH Consumer Discretionary
  • Exchange
  • TBPH Nasdaq
  • BZH Nasdaq
  • Market Cap
  • TBPH 699.0M
  • BZH 717.3M
  • IPO Year
  • TBPH N/A
  • BZH 1994
  • Fundamental
  • Price
  • TBPH $14.75
  • BZH $22.13
  • Analyst Decision
  • TBPH Strong Buy
  • BZH Strong Buy
  • Analyst Count
  • TBPH 4
  • BZH 3
  • Target Price
  • TBPH $23.00
  • BZH $32.00
  • AVG Volume (30 Days)
  • TBPH 284.3K
  • BZH 283.4K
  • Earning Date
  • TBPH 11-10-2025
  • BZH 11-13-2025
  • Dividend Yield
  • TBPH N/A
  • BZH N/A
  • EPS Growth
  • TBPH N/A
  • BZH N/A
  • EPS
  • TBPH 0.26
  • BZH 2.23
  • Revenue
  • TBPH $77,205,000.00
  • BZH $2,385,816,000.00
  • Revenue This Year
  • TBPH $79.82
  • BZH N/A
  • Revenue Next Year
  • TBPH N/A
  • BZH $5.53
  • P/E Ratio
  • TBPH $59.49
  • BZH $9.83
  • Revenue Growth
  • TBPH 24.49
  • BZH 9.97
  • 52 Week Low
  • TBPH $7.90
  • BZH $17.37
  • 52 Week High
  • TBPH $15.34
  • BZH $38.22
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 58.51
  • BZH 36.67
  • Support Level
  • TBPH $14.11
  • BZH $22.35
  • Resistance Level
  • TBPH $15.34
  • BZH $24.51
  • Average True Range (ATR)
  • TBPH 0.42
  • BZH 0.71
  • MACD
  • TBPH 0.06
  • BZH -0.08
  • Stochastic Oscillator
  • TBPH 63.55
  • BZH 14.47

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: